Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells

Glucagon like peptide 1 (GLP-1) based therapies are now widely used for the treatment of type 2 diabetes. Developing our understanding of intestinal GLP-1 release may facilitate the development of new therapeutics aimed at targeting the GLP-1 producing L-cells. This study was undertaken to character...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, G J, Tolhurst, G, Ramzan, A, Habib, A M, Parker, H E, Gribble, F M, Reimann, F
Formato: Texto
Lenguaje:English
Publicado: Blackwell Science Inc 2011
Materias:
Molecular and Cellular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060588/
https://www.ncbi.nlm.nih.gov/pubmed/21224236
http://dx.doi.org/10.1113/jphysiol.2010.198069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060588/
https://www.ncbi.nlm.nih.gov/pubmed/21224236
http://dx.doi.org/10.1113/jphysiol.2010.198069

Ejemplares similares